Skip to main content
Clinical Trials/CTRI/2019/06/019802
CTRI/2019/06/019802Completed未知

Clinical evaluation of the efficacy of Pushyanuga churna and Usheerasava in the management of Abnormal uterine bleeding(Asrigdara)

CCRAS0 sites68 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
68

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1)Excessive bleeding during menstruation (menstrual blood loss > 80 ml in 1-7 days) having score more than 100 points on Pictorial Blood Loss Assessment Chart (PBLAC) for 3 consecutive cycles or Prolonged menstrual bleeding (more than >7days) for 3 consecutive cycles or Frequent menses with interval of menstrual cycle < 21 days.
  • 2)Patient willing to participate for three months after written informed consent.
  • 3)Hemoglobin more than or equal to 7 gm%.

Exclusion Criteria

  • 1)Patients having pelvic pathologies like Polyp, Adenomyosis, Leiomyoma, Malignancy and Hyperplasia and Cervical erosion.
  • 2)Other causes of excessive menstrual bleeding like Intra Uterine Contraceptive Devices and thyroid dysfunction.
  • 3)Blood Dyscrasias; diseases of platelets, clotting factors, diseases of RBCs and WBCs.
  • 4)Incomplete abortion

Investigators

Sponsor
CCRAS

Similar Trials